Skip to content
← Full study record

NCT03951220 · OUTCOME

Primary Outcome 1+2: Quantifying Tumour Burden (Total Spinal 'Collapse' Volume)

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss · Source last updated 2025-08-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
At baseline

What was measured

* This was intended as a novel end-point produced by OCMR scientists, in which high-resolution 3D imaging of the spine and pelvis are analysed for the extent of vertebral collapse. * Unfortunately, we were unable to collect data for the total spinal hole volume and total spine collapse volume at the point of novel magnetic resonance (MR) scan, due to technical challenges.

Analysis population: \- Unfortunately, we were unable to collect data for the total spinal hole volume and total spine collapse volume at the point of novel MR scan, due to technical challenges.

Groups in this outcome

Group 1- Myeloma

Group 1a: New Myeloma; Group 1b: Relapsed Myeloma Group;1c: Smouldering Myeloma Baseline AND Follow-Up Assessment: Novel MR Whole body DXA scan Blood and urine samples QOL \& scan experience questionnaires

Group 2- MGUS

Baseline AND Follow-Up Assessment: Novel MR Whole body DXA scan Blood and urine samples QOL \& scan experience questionnaires

Group 3- Healthy Volunteers

Baseline Assessment ONLY: * Novel MR * QOL \& scan experience questionnaires

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Group 1- Myeloma0
Group 2- MGUS0
Group 3- Healthy Volunteers0

Reported measurements

Largest spinal collapse volume
Total spinal collapse volume
Complete source fields
classes
  1. title
    Largest spinal collapse volume
  2. title
    Total spinal collapse volume
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      0
    3. group Id
      OG002
      value
      0
    units
    Participants
description
* This was intended as a novel end-point produced by OCMR scientists, in which high-resolution 3D imaging of the spine and pelvis are analysed for the extent of vertebral collapse. * Unfortunately, we were unable to collect data for the total spinal hole volume and total spine collapse volume at the point of novel magnetic resonance (MR) scan, due to technical challenges.
groups
  1. description
    Group 1a: New Myeloma; Group 1b: Relapsed Myeloma Group;1c: Smouldering Myeloma Baseline AND Follow-Up Assessment: Novel MR Whole body DXA scan Blood and urine samples QOL \& scan experience questionnaires
    id
    OG000
    title
    Group 1- Myeloma
  2. description
    Baseline AND Follow-Up Assessment: Novel MR Whole body DXA scan Blood and urine samples QOL \& scan experience questionnaires
    id
    OG001
    title
    Group 2- MGUS
  3. description
    Baseline Assessment ONLY: * Novel MR * QOL \& scan experience questionnaires
    id
    OG002
    title
    Group 3- Healthy Volunteers
population Description
\- Unfortunately, we were unable to collect data for the total spinal hole volume and total spine collapse volume at the point of novel MR scan, due to technical challenges.
reporting Status
POSTED
time Frame
At baseline
title
Primary Outcome 1+2: Quantifying Tumour Burden (Total Spinal 'Collapse' Volume)
type
PRIMARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice